AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 1 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,914 | -42.5% | 300,000 | 0.0% | 0.08% | -20.4% |
| Q2 2023 | $3,327 | -57.7% | 300,000 | -41.4% | 0.10% | -77.9% |
| Q1 2023 | $7,859 | -29.2% | 511,962 | +2.4% | 0.47% | -24.6% |
| Q4 2022 | $11,095 | -99.7% | 500,000 | +100.0% | 0.62% | +255.7% |
| Q3 2022 | $4,083,000 | +12.4% | 250,000 | 0.0% | 0.17% | -10.3% |
| Q2 2022 | $3,633,000 | -21.3% | 250,000 | 0.0% | 0.19% | +0.5% |
| Q1 2022 | $4,618,000 | -22.3% | 250,000 | 0.0% | 0.19% | +19.9% |
| Q4 2021 | $5,943,000 | +69.3% | 250,000 | +75.4% | 0.16% | +103.8% |
| Q3 2021 | $3,510,000 | -0.3% | 142,500 | 0.0% | 0.08% | +11.3% |
| Q2 2021 | $3,521,000 | +13.3% | 142,500 | 0.0% | 0.07% | +29.1% |
| Q1 2021 | $3,108,000 | -14.5% | 142,500 | 0.0% | 0.06% | -29.5% |
| Q4 2020 | $3,637,000 | -9.3% | 142,500 | 0.0% | 0.08% | -19.6% |
| Q3 2020 | $4,011,000 | -18.9% | 142,500 | -18.6% | 0.10% | -29.7% |
| Q2 2020 | $4,946,000 | – | 175,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |